By G. Hasko
Read Online or Download Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases PDF
Similar diseases books
This ebook presents a cutting-edge evaluation of key matters regarding antimicrobial resistance, together with a spotlight on key pathogens inflicting universal healthcare-associated and community-acquired infections. The epidemiology and healing issues of those antimicrobial resistant organisms are mentioned, in addition to the scientific and well-being monetary impression of infections brought on by them.
This can be a 3-in-1 reference publication. It provides an entire clinical dictionary overlaying hundreds of thousands of phrases and expressions in relation to balanitis. It additionally provides vast lists of bibliographic citations. ultimately, it offers info to clients on the best way to replace their wisdom utilizing numerous net assets.
Fungal illnesses were with us from antiquity; curiosity within the chemo treatment of fungal ailment has exploded long ago decade. to plot and seasoned duce a e-book regarding antifungal chemotherapy has come as a private problem - and whatever of an eye-opener - in the direction of the top of my re seek profession.
Imaging reports are enjoying an more and more position within the evaluate of endocrine ailments; hence, familiarity with the categorical symptoms for some of the modalities, and with the attribute findings, is key. This multi-author paintings, that's meant for either radiologists and endocrinologists, considers the position of all of the fresh imaging ideas, together with ultrasound (particular colour Doppler), computed tomography, MRI, and scintigraphy.
Extra resources for Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases
W. , 2,5′-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A1, A2A, and A3 receptor, J. Med. , 45, 420, 2002. 21. N. , 2-Substituted N-ethylcarboxamidoadenosine derivatives as highaffinity agonists at human A3 adenosine receptors, Naunyn-Schmiedeberg’s Arch. , 360, 103, 1999. 22. Elzein, E. , 2-Pyrazolyl-N6-substituted adenosine derivatives as high affinity and selective adenosine A3 receptor agonists, J. Med. , 47, 4766, 2004. 23. G. , Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor, J.
Moro, S. , Autocorrelation of molecular electrostatic potential surface properties combined with partial least squares analysis as new strategy for the prediction of the activity of human A3 adenosine receptor antagonists, J. Med. , 48, 5698, 2005. 34. J. , A binding site model and structure-activity relationships for the rat A3 adenosine receptor, Mol. , 45, 1101, 1994. 35. , Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions, Trends Pharmacol.
Med. , 4, 863, 2004. 56. J. , A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential, Bioorg. Med. Chem. , 15, 3081, 2005. 57. Saki, M. , KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist, Eur. J. , 444, 133, 2002. fm Page 38 Wednesday, June 14, 2006 11:22 AM 38 Adenosine Receptors 58. E. , Imidazo[2,1-i]purin-5-ones and related tricyclic water-soluble purine derivatives: potent A2A- and A3-adenosine receptor antagonists, J.
Adenosine Receptors - Therapeutic Asps. for Inflamm., Immune Diseases by G. Hasko